Susquehanna International Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $925K | Sell |
82,365
-30,351
| -27% | -$341K | ﹤0.01% | 3376 |
|
|
2025
Q1 | $515K | Buy |
112,716
+70,232
| +165% | +$321K | ﹤0.01% | 4306 |
|
|
2024
Q4 | $240K | Sell |
42,484
-31,264
| -42% | -$176K | ﹤0.01% | 5039 |
|
|
2024
Q3 | $357K | Sell |
73,748
-118,658
| -62% | -$574K | ﹤0.01% | 4085 |
|
|
2024
Q2 | $939K | Buy |
192,406
+139,882
| +266% | +$683K | ﹤0.01% | 2652 |
|
|
2024
Q1 | $698K | Sell |
52,524
-76,192
| -59% | -$1.01M | ﹤0.01% | 3077 |
|
|
2023
Q4 | $1.79M | Buy |
128,716
+95,589
| +289% | +$1.33M | ﹤0.01% | 2067 |
|
|
2023
Q3 | $439K | Buy |
33,127
+12,264
| +59% | +$163K | ﹤0.01% | 3595 |
|
|
2023
Q2 | $391K | Sell |
20,863
-97,575
| -82% | -$1.83M | ﹤0.01% | 3939 |
|
|
2023
Q1 | $1.71M | Buy |
118,438
+45,019
| +61% | +$649K | ﹤0.01% | 2156 |
|
|
2022
Q4 | $1.42M | Sell |
73,419
-23,993
| -25% | -$464K | ﹤0.01% | 1944 |
|
|
2022
Q3 | $3.35M | Buy |
97,412
+76,802
| +373% | +$2.64M | ﹤0.01% | 1155 |
|
|
2022
Q2 | $315K | Sell |
20,610
-26,247
| -56% | -$401K | ﹤0.01% | 3936 |
|
|
2022
Q1 | $1.07M | Sell |
46,857
-10,405
| -18% | -$237K | ﹤0.01% | 2733 |
|
|
2021
Q4 | $2.11M | Buy |
+57,262
| New | +$2.11M | ﹤0.01% | 1918 |
|
|
2021
Q3 | – | Sell |
-28,525
| Closed | -$1.72M | – | 6130 |
|
|
2021
Q2 | $1.72M | Buy |
+28,525
| New | +$1.72M | ﹤0.01% | 2250 |
|